Literature DB >> 3391368

Effect of ursodeoxycholic acid on biliary lipid coupling and on cholesterol absorption during fasting and eating in subjects with cholesterol gallstones.

A Lanzini1, T C Northfield.   

Abstract

The aim of this study was to determine the effect of chronic ursodeoxycholic acid administration on coupling of bile acids with cholesterol and phospholipid in hepatic bile, and on cholesterol absorption in the duodenum. A range of bile acid secretion rates was obtained during an evening meal and an overnight fast. Duodenal perfusion of polyethylene glycol as a nonabsorbable recovery marker and of [3H]cholesterol and [14C]lecithin as absorbable recovery markers was combined with continuous intravenous infusion of indocyanine green as a hepatic bile marker. Six subjects with gallstones were studied before and during chronic administration of ursodeoxycholic acid (675 mg/day). Duplicate pretreatment studies revealed good reproducibility for biliary lipid coupling and cholesterol absorption. During ursodeoxycholic acid administration there was a significant alteration not only in bile acid/cholesterol coupling (p less than 0.001), but also in bile acid/phospholipid coupling (p less than 0.001). Mean cholesterol absorption decreased from 25% to 15% (p less than 0.001) during ursodeoxycholic acid administration. These effects of chronic ursodeoxycholic acid administration on biliary lipid coupling are similar to those reported for acute administration, and are thus consistent with an effect caused by bile acid lipid-solubilizing capacity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3391368     DOI: 10.1016/0016-5085(88)90498-2

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  5 in total

1.  Hepatic biliary lipid secretion and gall bladder biliary lipid mass in gall stone patients: effect of ursodeoxycholic acid.

Authors:  A Lanzini; T C Northfield
Journal:  Gut       Date:  1990-02       Impact factor: 23.059

2.  Effect of long term simvastatin administration as an adjunct to ursodeoxycholic acid: evidence for a synergistic effect on biliary bile acid composition but not on serum lipids in humans.

Authors:  F Lanzarotto; B Panarotto; R Sorbara; M Panteghini; F Pagani; S Sosta; A Lanzini
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

3.  Effect of ursodeoxycholic acid treatment on ileal absorption of bile acids in man as determined by the SeHCAT test.

Authors:  S Eusufzai; S Ericsson; T Cederlund; K Einarsson; B Angelin
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

Review 4.  Pharmacological treatment of gallstones. Practical guidelines.

Authors:  A Lanzini; T C Northfield
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

5.  Hepatocyte ATF3 protects against atherosclerosis by regulating HDL and bile acid metabolism.

Authors:  Yanyong Xu; Yuanyuan Li; Kavita Jadhav; Xiaoli Pan; Yingdong Zhu; Shuwei Hu; Shaoru Chen; Liuying Chen; Yong Tang; Helen H Wang; Ling Yang; David Q-H Wang; Liya Yin; Yanqiao Zhang
Journal:  Nat Metab       Date:  2021-01-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.